Vibeke Strand, MD, on the Future of JAK Inhibitors for Immune-Mediated Inflammatory Diseases

In this video, Vibeke Strand, MD, highlights current JAK inhibitors for the treatment of immune-mediated inflammatory diseases, how they may be used in the future, and more.

Additional Resources:

Interdisciplinary Autoimmune Summit 

Vibeke Strand, MD, is a clinical rheumatologist in California, as well as a biopharmaceutical consultant. 

Published in partnership with IAS Meeting


Submit Feedback